Holdings

Ra Capital Management, L.P.

As of Sep 30, 2026, Ra Capital Management, L.P. reported 84 positions worth US$7.11B. Largest: Parabilis Medicines, Inc., Vaxcyte, Inc. and Rhythm Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Parabilis Medicines, Inc.29.2MUS$942M+245KSep 30, 2026
Vaxcyte, Inc.11.5MUS$653Mno changeSep 30, 2026
Rhythm Pharmaceuticals, Inc.6.67MUS$635Mno changeSep 30, 2026
Edgewise Therapeutics, Inc.8.39MUS$341Mno changeSep 30, 2026
Tyra Biosciences, Inc.12.2MUS$267Mno changeSep 30, 2026
Freenome, Inc.15.4MUS$242MnewSep 30, 2026
Hemab Therapeutics Holdings, Inc.7.81MUS$241Mno changeSep 30, 2026
Septerna, Inc.5.5MUS$215M−1.49MSep 30, 2026
SpyGlass Pharma, Inc.8.02MUS$209Mno changeSep 30, 2026
Janux Therapeutics, Inc.11.2MUS$193Mno changeSep 30, 2026